Resistance to trimethoprim emerged in Enterobacteria- ceae and later i
n other Gram-negative and Gram-positive bacteria within two years of t
he clinical introduction of the drug. Resistance is borne in many diff
erent replicons often present in multiply-resistant epidemic bacteria.
The incidence of trimethoprim resistance is highly variable, dependin
g upon methodology, type of patients, local epidemiology: this can be
illustrated by the high variation of trimethoprim resistance among Sal
monella, Shigella or MRSA in various countries and by the incidence of
resistance in penicillin-resistant Streptococcus pneumoniae.